INmune Bio Inc (INMB)
6.21
+0.17
(+2.81%)
USD |
NASDAQ |
Nov 04, 16:00
6.21
0.00 (0.00%)
After-Hours: 20:00
INmune Bio Price: 6.21 for Nov. 4, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 01, 2024 | 5.94 | 6.37 | 5.89 | 6.04 | 225027.0 |
| Oct 31, 2024 | 5.91 | 5.985 | 5.67 | 5.85 | 168963.0 |
| Oct 30, 2024 | 6.26 | 6.46 | 5.76 | 5.95 | 311260.0 |
| Oct 29, 2024 | 6.25 | 6.66 | 6.147 | 6.30 | 534115.0 |
| Oct 28, 2024 | 5.65 | 6.53 | 5.65 | 6.165 | 622677.0 |
| Oct 25, 2024 | 5.30 | 5.74 | 5.213 | 5.42 | 496066.0 |
| Oct 24, 2024 | 5.00 | 5.35 | 4.97 | 5.22 | 316867.0 |
| Oct 23, 2024 | 5.08 | 5.18 | 4.89 | 5.00 | 175186.0 |
| Oct 22, 2024 | 5.19 | 5.21 | 5.02 | 5.14 | 111125.0 |
| Oct 21, 2024 | 5.23 | 5.32 | 5.03 | 5.18 | 172059.0 |
| Oct 18, 2024 | 5.06 | 5.115 | 5.01 | 5.11 | 126452.0 |
| Oct 17, 2024 | 5.21 | 5.21 | 4.87 | 5.00 | 119970.0 |
| Oct 16, 2024 | 4.87 | 5.22 | 4.87 | 5.21 | 188971.0 |
| Oct 15, 2024 | 5.02 | 5.065 | 4.78 | 4.83 | 243067.0 |
| Oct 14, 2024 | 5.11 | 5.23 | 5.000 | 5.08 | 129198.0 |
| Oct 11, 2024 | 5.01 | 5.15 | 4.97 | 5.14 | 109945.0 |
| Oct 10, 2024 | 5.10 | 5.105 | 4.87 | 5.02 | 187659.0 |
| Oct 09, 2024 | 5.29 | 5.29 | 5.045 | 5.14 | 169451.0 |
| Oct 08, 2024 | 5.24 | 5.34 | 5.13 | 5.31 | 125459.0 |
| Oct 07, 2024 | 5.43 | 5.43 | 5.195 | 5.24 | 119275.0 |
| Oct 04, 2024 | 5.37 | 5.47 | 5.166 | 5.46 | 147248.0 |
| Oct 03, 2024 | 5.31 | 5.48 | 5.265 | 5.30 | 269122.0 |
| Oct 02, 2024 | 5.50 | 5.50 | 5.09 | 5.31 | 322880.0 |
| Oct 01, 2024 | 5.42 | 5.73 | 5.37 | 5.51 | 381010.0 |
| Sep 30, 2024 | 5.42 | 5.42 | 5.23 | 5.39 | 402881.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.21
Minimum
Mar 18 2020
27.85
Maximum
Sep 07 2021
9.694
Average
8.60
Median
Nov 16 2020
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.78 |
| Palatin Technologies Inc | 1.20 |
| iBio Inc | 2.66 |
| Theriva Biologics Inc | 2.08 |
| Oragenics Inc | 0.3089 |
Price Related Metrics
| PS Ratio | 895.26 |
| PEG Ratio | -0.1121 |
| Price to Book Value | 3.560 |
| Earnings Yield | -35.10% |
| Market Cap | 122.85M |
| PEGY Ratio | -0.1121 |